Trust Co. of Vermont Acquires New Stake in Cardinal Health, Inc. $CAH

Trust Co. of Vermont bought a new position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 4,206 shares of the company’s stock, valued at approximately $999,000.

A number of other institutional investors have also added to or reduced their stakes in CAH. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $141,723,000. OneDigital Investment Advisors LLC bought a new position in shares of Cardinal Health in the second quarter worth approximately $590,000. Plato Investment Management Ltd purchased a new stake in Cardinal Health in the second quarter valued at approximately $1,933,000. Bell Investment Advisors Inc purchased a new stake in Cardinal Health in the second quarter valued at approximately $45,000. Finally, Simplicity Wealth LLC bought a new stake in Cardinal Health during the second quarter valued at approximately $486,000. 87.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on CAH shares. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. TD Cowen lifted their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a report on Thursday, August 13th. William Blair started coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Barclays raised their price target on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $265.93.

View Our Latest Stock Analysis on CAH

Cardinal Health Stock Performance

Shares of CAH opened at $234.85 on Wednesday. The firm has a market cap of $54.62 billion, a price-to-earnings ratio of 32.48, a PEG ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The firm has a 50 day moving average price of $231.38 and a 200-day moving average price of $217.51.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.